Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: A pilot study

Journal of Psychiatric Research

Volumn 41, Issue 3-4, 2007, Pages 319-325

  Bares, Martin ^a,b   Brunovsky, Martin ^a,b   Kopecek, Miloslav ^a,b   Stopkova, Pavla ^a,b   Novak, Tomas ^a,b   Kozeny, Jiri ^a,b   Höschl, Cyril ^a,b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Antidepressants; Cordance; QEEG; Response prediction; Treatment resistant depression

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; ESCITALOPRAM; MILNACIPRAN; MIRTAZAPINE; VENLAFAXINE;

ADULT; ARTICLE; BRAIN PERFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG MONITORING; DRUG RESPONSE; ELECTRODE; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PILOT STUDY; PREDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; STATISTICAL SIGNIFICANCE; THERAPY RESISTANCE; THETA RHYTHM; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 33845214068     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2006.06.005     Document Type: Article

References (33)

1. Asada H., Fukuda Y., Tsunoda S., Yamaguchi M., and Tonoike M. Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans. Neuroscience Letters 274 (1999) 29-32
2. Beck A.T., and Beamesderfer A. Assessment of depression: the depression inventory. Modern Problems of Pharmacopsychiatry 7 (1974) 151-169
3. Beck A.T., Rial W.Y., and Rickels K. Short form of depression inventory: cross-validation. Psychological Reports 34 (1974) 1184-1186
4. Cook I.A., and Leuchter A.F. Prefrontal changes and treatment response prediction in depression. Seminars of Clinical Neuropsychiatry 6 (2001) 113-120
5. Cook I.A., O'Hara R., Uijtdehaage S., Mandelkern M., and Leuchter A.F. Assessing the accuracy of topographic EEG mapping for determining local brain function. Electroencephalography and Clinical Neurophysiology 107 (1998) 404-414
6. Cook I.A., Leuchter A.F., Witte E., Abrams M., Uijtdehaage S.H., Stubbeman W., et al. Neurophysiologic predictors of treatment response to fluoxetine in major depression. Psychiatry Research 85 (1999) 263-273
7. Cook I.A., Leuchter A.F., Morgan M., Witte E., Stubbeman W.F., Abrams M., et al. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology 27 (2002) 120-131
8. Cook I.A., Leuchter A.F., Morgan M.L., Stubbeman W., Siegman B., and Abrams M. Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. Journal of Psychiatric Research 39 (2005) 461-466
9. Dodd S., and Berk M. Predictors of antidepressant response: a selective review. International Journal of Psychiatry in Clinical Practice 8 (2004) 91-100
10. Gilbert D.G., Dibb W.D., Plath L.C., and Hiyane S.G. Effects of nicotine and caffeine, separately and in combination, on EEG topography, mood, heart rate, cortisol, and vigilance. Psychophysiology 37 (2000) 583-595
11. Guy W. ECDEU assessment manual for psychopharmacology, revised 1976 (1976), National Institutes of Mental Health, Rockville (MD)
12. Herrmann W.M., Scharer E., Wendt G., and Delini-Stula A. Pharmaco-EEG profile of levoprotiline: second example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs. Pharmacopsychiatry 24 (1991) 206-213
13. Hjorth B. An on line transformation of EEG scalp potentials into orthogonal source derivations. Electroencephalography and Clinical Neurophysiology 39 (1975) 526-530
14. Leuchter A.F., Cook I.A., Lufkin R.B., Dunkin J., Newton T.F., Cummings J.L., et al. Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography. Neuroimage 1 (1994) 208-219
15. Leuchter A.F., Uijtdehaage S.H., Cook I.A., O'Hara R., and Mandelkern M. Relationship between brain electrical activity and cortical perfusion in normal subjects. Psychiatry Research - Neuroimaging 90 (1999) 125-140
16. Leuchter A.F., Cook I.A., Witte E.A., Morgan M., and Abrams M. Changes in brain function of depressed subjects during treatment with placebo. American Journal of Psychiatry 159 (2002) 122-129
17. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickan J.S., Tekell J.L., et al. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8 (1997) 1057-1061
18. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biological Psychiatry 48 (2000) 830-843
19. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., et al. Deep brain stimulation for treatment-resistant depression. Neuron 45 (2005) 651-660
20. Montgomery S.A., and Åsberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134 (1979) 382-389
21. Ngan E.T., Lane C.J., Ruth T.J., and Liddle P.F. Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naive schizophrenic patients: correlations with symptom change. Journal of Neurology, Neurosurgery & Psychiatry 72 (2002) 106-110
22. Nobler M.S., Oquendo M.A., Kegeles L.S., Malone K.M., Campbell C., Sackeim H.A., et al. Decreased regional brain metabolism after ECT. American Journal of Psychiatry 158 (2001) 305-308
23. Pizzagalli D., Pascual-Marqui R.D., Nitschke J.B., Oakes T.R., Larson C.L., Abercrombie H.C., et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. American Journal of Psychiatry 158 (2001) 405-415
24. Pizzagalli D.A., Oakes T.R., and Davidson R.J. Coupling of theta activity and glucose metabolism in the human rostral anterior cingulate cortex: an EEG/PET study of normal and depressed subjects. Psychophysiology 40 (2003) 939-949
25. Posternak M.A., and Zimmerman M. Is there a delay in the antidepressant effect? A meta-analysis. Journal of Clinical Psychiatry 66 (2005) 148-158
26. Pridmore S., and Turnier-Shea Y. Medication options in the treatment of treatment-resistant depression. Australian and New Zealand Journal of Psychiatry 38 (2004) 219-225
27. Pritchard W.S., Robinson J.H., DeBethizy J.D., Davis R.A., and Stiles M.F. Caffeine and smoking: subjective, performance, and psychophysiological effects. Psychophysiology 32 (1995) 19-27
28. Sackeim H.A., Roose S.P., and Burt T. Optimal length of antidepressant trials in late-life depression. Journal of Clinical Psychopharmacology 25 Suppl. 1 (2005) S34-S37
29. Saletu B., and Gruenberger J. Drug profiling by computed electroencephalography and brain maps with special consideration of sertraliie and its psychometric effects. Journal of Clinical Psychiatry 49 Suppl. (1988) 59-71
30. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59 Suppl. 20 (1998) 22-33
31. Smith G.S., Reynolds III C.F., Houck P.R., Dew M.A., Ma Y., Mulsant B.H., et al. Glucose metabolic response to total sleep deprivation, recovery sleep, and acute antidepressant treatment as functional neuroanatomic correlates of treatment outcome in geriatric depression. American Journal of Geriatric Psychiatry 10 (2002) 561-567
32. Thase M.E., and Rush A.J. When at first you don't succeed: sequential strategies for antidepressant nonresponders. Journal of Clinical Psychiatry 58 Suppl. 13 (1997) 23-29
33. Ulrich G., Haug H.J., Stieglitz R.D., and Fahndrich E. EEG characteristics of clinically defined on-drug-responders and nonresponders-a comparison clomipramine vs. maprotiline. Pharmacopsychiatry 21 (1988) 367-368